AstraZeneca’s covid-19 (mis)adventure and the future of vaccine equity

BMJ (Online), 2022-11, Vol.379, p.o2592-o2592 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;This article is made freely available for personal use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.o2592 ;PMID: 36368703

Full text available